)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Pacific Biosciences of California (PACB) investor relations material
Pacific Biosciences of California Stephens Annual Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Stephens Annual Investment Conference summary19 Nov, 2025
Industry trends and market dynamics
Long read sequencing is gaining traction due to recent data showing it detects more structural variants than short read, with studies like All of Us and HiFi consortium highlighting its advantages.
Cost has been a major barrier, but new chemistry (Spark Next) is bringing long read closer to cost parity with short read, enabling broader adoption.
Market share is currently 1-2%, but increased customer interest and product improvements signal a potential inflection point for growth.
Collaboration and data enrichment with other players, such as Oxford, are seen as synergistic for advancing the field.
PopGen studies and clinical applications are driving new demand, with large-scale projects now considering long read for a significant portion of their sequencing.
Product innovation and differentiation
Recent product launches, including Spark and Spark Next chemistries, have reduced sample requirements and costs, and increased throughput.
Long read technology enables detection of structural variants and repeat expansions not visible with short read, supporting rare disease and carrier testing.
New instruments like Revio and Vega are attracting both new and existing customers, with Vega serving as an entry point and Revio for higher throughput needs.
Software and AI integration are expected to unlock further value from long read data in the next 2-3 years.
Targeted assays (e.g., Pure Target) are being developed for clinical diagnostics where short read is insufficient.
Commercial strategy and financial outlook
Focus is shifting from academic to clinical and hospital segments due to more predictable demand and higher consumable utilization.
Strategic discounting has been used for anchor accounts, but ASPs are expected to normalize as volume and utilization increase.
Consumable mix is a key driver for gross margin improvement, with production efficiencies in Revio and Vega also contributing.
Operating expenses are being tightly managed, with 2026 OpEx expected to be lower than 2025, supporting the goal of cash flow positivity by end of 2027.
Early access and beta programs for new chemistries are being used to manage rollout and ensure quality and utilization before full release.
Which clinical segments are key for long-read adoption?
Spark Next: How to balance price and volume?
What unlocks the 'whole genome test backbone' vision?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Pacific Biosciences of California earnings date
Piper Sandler 37th Annual Healthcare Conference3 Dec, 2025
Next Pacific Biosciences of California earnings date
Piper Sandler 37th Annual Healthcare Conference3 Dec, 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company’s single molecule real-time (SMRT™) Sequencing platform enables single molecule real-time detection of biological processes. Its SMRT Sequencing technology provides various applications, including de novo sequencing to assemble a genome from scratch; targeted sequencing to sample specific regions of interest; and epigenetic sequencing to study how environmental factors affect gene expression. It has collaboration with Cold Spring Harbor Laboratory to expand its efforts in developing third-generation DNA sequencing technology.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage